Branched-chain alpha-keto acid dehydrogenase complex

Overall reaction catalyzed by the branched-chain alpha-keto acid dehydrogenase complex

The branched-chain alpha-keto acid dehydrogenase complex (BCKDC) is a multi-enzyme complex that plays a crucial role in the catabolism of branched-chain amino acids (BCAAs) such as leucine, isoleucine, and valine. This complex is responsible for the oxidative decarboxylation of branched-chain alpha-keto acids, which are derived from the transamination of BCAAs.

Structure

The BCKDC is a large, multi-subunit complex composed of multiple copies of three catalytic components:

1. E1 component: Branched-chain alpha-keto acid dehydrogenase (BCKD), which requires thiamine pyrophosphate (TPP) as a cofactor. 2. E2 component: Dihydrolipoyl transacylase, which contains a lipoamide "swinging arm" that transfers acyl groups. 3. E3 component: Dihydrolipoamide dehydrogenase, which uses FAD and NAD+ as cofactors to regenerate the oxidized form of lipoamide.

The "swinging arm" of the BCKDC E2 component

Function

The primary function of the BCKDC is to catalyze the conversion of branched-chain alpha-keto acids into their corresponding acyl-CoA derivatives, which can then enter the citric acid cycle or be used in other metabolic pathways. This reaction is a key step in the catabolism of BCAAs, which are essential amino acids that must be obtained from the diet.

Catalytic Mechanism

The catalytic mechanism of BCKDC involves several steps:

1. Decarboxylation: The E1 component catalyzes the decarboxylation of the alpha-keto acid, forming an acyl-TPP intermediate.

Step 1: Decarboxylation of the alpha-keto acid

2. Acyl transfer: The acyl group is transferred to the lipoamide "swinging arm" of the E2 component, forming an acyl-lipoamide intermediate.

Step 2: Acyl transfer to the lipoamide arm

3. CoA transfer: The acyl group is transferred from the lipoamide to CoA, forming acyl-CoA. 4. Regeneration: The E3 component regenerates the oxidized form of lipoamide, using FAD and NAD+ as cofactors.

Regulation

The activity of BCKDC is tightly regulated by phosphorylation and dephosphorylation. The complex is inactivated by phosphorylation of the E1 component by a specific kinase, and reactivated by dephosphorylation by a specific phosphatase. This regulation allows the cell to control the breakdown of BCAAs according to metabolic needs.

Clinical Significance

Deficiencies in BCKDC activity can lead to metabolic disorders such as maple syrup urine disease (MSUD), which is characterized by the accumulation of branched-chain amino acids and their corresponding keto acids in the blood and urine. MSUD can lead to neurological damage and other severe symptoms if not managed properly.

Also see

• Branched-chain amino acid metabolism
• Maple syrup urine disease
• Citric acid cycle
• Amino acid catabolism

   This article is a enzyme-related stub. You can help WikiMD by expanding it!